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Public Health Program
The Open Society Institute’s Public Health Program aims to build societies committed to inclusion, 
human rights, and justice, in which health-related laws, policies, and practices are evidence-based 
and reﬂect these values. The program works to advance the health and human rights of marginalized 
people by building the capacity of civil society leaders and organizations, and by advocating for 
greater accountability and transparency in health policy and practice. The Public Health Program 
engages in ﬁve core strategies to advance its mission and goals: grantmaking, capacity building, 
advocacy, strategic convening, and mobilizing and leveraging funding. The Public Health Program 
works in Central and Eastern Europe, Southern and Eastern Africa, Southeast Asia, and China.
International Harm Reduction Development Program
The International Harm Reduction Development Program (IHRD), part of the Open Society 
Institute’s Public Health Program, works to reduce HIV and other harms related to injecting drug 
use and to press for policies that reduce stigmatization of illicit drug users and protect their human 
rights. Since 1995 IHRD has supported more than 200 programs in Central and Eastern Europe and 
Asia, and bases its activities on the philosophy that people unable or unwilling to abstain from drug 
use can make positive changes to protect their health and the health of others. Since 2001, IHRD 
has prioritized advocacy to expand availability and quality of needle exchange, drug dependence 
treatment, and treatment for HIV; to reform discriminatory policies and practices; and to increase 
the participation of people who use drugs and those living with HIV in shaping policies that affect 
their lives.
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5About this Report
This report focuses on the introduction of harm reduction programs in Moldovan 
prisons and describes successes achieved as well as remaining challenges. Research 
was conducted in Moldova in August 2007 and October 2008, with seven site visits 
to prisons and one site visit to a pretrial detention facility, as well as visits to the 
headquarters of the penitentiary system and Innovative Projects in Prisons—a non-
governmental organization (NGO) that provides harm reduction services in prisons. 
The authors interviewed prisoners and pretrial detainees, NGO staff, and penitentiary 
system ofﬁcials and employees at both the national and local levels.
The extent of research conducted at each prison and pretrial detention facility 
varied due to several factors, including: length and timing of visit; staff responsibilities 
and availability at the time; and access to prisoners and their ability and willingness to 
talk. Citations are provided when appropriate to identify the sources of information, 
observations, opinions, and direct quotes. Any errors are the fault of the authors.
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91. Introduction
Prevalence of HIV infection among prisoners in many countries is signiﬁcantly higher 
than in the general population.1 Hepatitis C virus prevalence is even higher.2 Most 
prisoners living with HIV contract their infection prior to imprisonment. However, 
the risk of being infected in prison, speciﬁcally through the sharing of contaminated 
injecting equipment, is high. Even countries that have invested heavily in drug demand 
and drug supply reduction efforts in prisons have not been able to stop injecting drug 
use.3 Outbreaks of HIV infection caused by sharing injection equipment in prisons 
demonstrate how rapidly HIV can spread in detention settings unless effective action 
is taken to prevent transmission.4
Internationally, the importance of implementing comprehensive HIV interven-
tions, including needle exchange and methadone maintenance programs, in prisons 
was recognized early in the epidemic. After holding its ﬁrst consultation on prevention 
and control of HIV in prisons in 1987, the World Health Organization responded to 
growing evidence and issued guidelines on HIV infection and AIDS in prisons in 
1993. With regard to health care and prevention of HIV, the guidelines emphasize 
that “all prisoners have the right to receive health care, including preventive measures, 
equivalent to that available in the community without discrimination, in particular 
with respect to their legal status or nationality.”5 
An increasing number of countries have introduced HIV programs in prisons 
since the early 1990s. However, many of these programs exclude necessary interven-
tions such as needle exchange and methadone treatment. Not so in Moldova, whose 
experience with introducing and expanding a comprehensive HIV program, including 
such interventions, is described in this report. 
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Nearly a decade ago, top ofﬁcials in Moldova’s penitentiary system acknowledged 
that, as in prisons worldwide,6 it was impossible to prevent illegal drugs from entering 
their facilities and stop prisoners from having sex with one another. They realized that 
measures to prevent drugs from coming into prisons could reduce the ﬂow of drugs, 
but would never fully stamp out the illicit drug trade. They also realized that pretend-
ing that drug use is not occurring would only increase the spread of HIV infection 
among prisoners. 
In Moldova as in other countries, many people sentenced to prison are depen-
dent on drugs, and will continue to use drugs in prison. Some people begin using 
drugs only after they come to prison, often as a means to release tensions and to cope 
with being in an overcrowded and often-violent environment.7 Studies show that peo-
ple in prisons are typically much more likely to share injecting equipment than those 
outside of prison.8 Because it is more difﬁcult to smuggle needles and syringes into 
prisons than it is to smuggle drugs, needles and syringes are often in short supply. At 
the same time, sexual activity, including rape and other forms of sexual violence, also 
occur in prisons and can result in transmission of HIV and other sexually transmit-
ted infections (STIs) when condoms are not provided and measures to prevent sexual 
violence are not taken.9
Moldovan authorities have demonstrated leadership, and pragmatism, in 
adopting evidence-based HIV prevention programs. Since 1999, local NGOs have 
provided prisoners with HIV/AIDS education and a wide range of harm reduction 
services, including psychological support, counseling, and distribution of clean 
injection equipment and condoms. Ten years later, Moldova remains one of only a 
few countries in the world where comprehensive harm reduction services are available 
in prisons. Few other countries—and almost none in the former Soviet Union10—
grant prisoners free, anonymous, and conﬁdential access to such an extensive range 
of materials and supplies that can greatly reduce risks to their health and, ultimately, 
save their lives.
The NGOs that provide education and harm reduction services are unusual in 
that they are essentially single-purpose NGOs. The organization Medical Reforms in 
Penitentiary Institutions, with the help of several key individuals (including Alexei 
Ledora and Dumitru Laticevschi), started the programs and administered them until 
another organization, Innovative Projects in Prisons (IPP), was founded in 2002 and 
took over the programs. Both NGOs work exclusively in prisons and their only focus 
is to help prisoners involved in risky behaviors to protect their health. NGO staff 
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members say that they hope their clients will ultimately stop using drugs, but they 
recognize that many people are unable or unwilling to quit drug use in prison, and 
harm reduction measures are the most practical and effective way of stemming the 
spread of HIV.
In 2005 the Department of Penitentiary Institutions expanded the range of pre-
vention services in prisons and introduced a methadone program. Neither the harm 
reduction program nor the methadone program, which is run by the Department of 
Penitentiary Institutions, has had an easy road to follow. Among other things, the 
programs have faced severe funding constraints. As of October 2008, IPP had been 
unable to expand its harm reduction project to all prisons and pretrial detention insti-
tutions. Meanwhile, the number of prisoners beneﬁting from the methadone program, 
although growing, remains small (see Box 4).
Therefore, many challenges remain and will have to be addressed in order to 
guarantee comprehensive access to education and harm reduction services for all pris-
oners and pretrial detainees in Moldova. But they cannot and do not detract from the 
positive developments that began when the ﬁrst prisoner in need received a clean 
needle in 1999. More than two-thirds of adult prisoners sentenced in Moldova are 
incarcerated in facilities where they have access to harm reduction services. In all the 
prisons where harm reduction services are provided, the experience has been over-
whelmingly positive—needles have never been used as weapons against prison staff 
or fellow prisoners, drug use has not increased, and available data suggest a reduction 
in HIV and hepatitis C incidence. 
Because of the training that has preceded and accompanied service delivery, 
awareness about HIV and risk behaviors is now nearly universal among prisoners 
and prison staff, from guards to administrators. The awareness has helped reduce 
HIV-related discrimination and stigma, thereby improving the lives of prisoners liv-
ing with HIV.
The introduction and expansion of harm reduction measures in Moldova’s pris-
ons have attracted signiﬁcant international attention over the years. Ofﬁcials from pen-
itentiary systems in a number of countries—including Azerbaijan, Bulgaria, Canada, 
Lithuania, Poland, and Ukraine—have visited Moldova and toured the prisons where 
harm reduction services are offered. They have talked to administrators, medical per-
sonnel, the prisoners who serve as outreach volunteers, and prisoners who use the 
services. They have seen the data and heard the observations, all of which point to suc-
cess of varying degrees in the project’s primary purpose: improving prisoners’ health, 
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and doing so without prompting commensurate negative changes such as increased 
drug use.
Importantly, the introduction of harm reduction measures has in recent years 
been accompanied by a drastic reduction in the number of prisoners and pretrial 
detainees; it has also been accompanied by other prison reform initiatives aimed at 
improving conditions for both prisoners and staff. Such measures, including reduction 
of overcrowding, increased work activities for prisoners, better food, and better pay for 
prison staff, have long been recognized as essential—although often neglected—com-
ponents of the overall effort to reduce the spread of infectious diseases in places of 
detention and to improve the health of prisoners and pretrial detainees.11
Moldova’s efforts should be examined closely by other prison systems, and 
adapted wherever possible. Ultimately, the health and well-being of all members of 
society, prisoners or not, are improved by virtue of pragmatic and comprehensive 
interventions in places of detention. 
One of the most important lessons from the Moldova experience is that suc-
cess of harm reduction initiatives can be greatly enhanced when top-level staff are 
engaged and proactive from the start. Both the director general and medical director 
of Moldova’s Department of Penitentiary Institutions have been strong supporters of 
the needle and syringe and methadone programs from early on. They were not afraid 
to use their authority to remove potential and existing obstacles. They ordered ofﬁcials 
at local prisons to implement the needle and syringe project and cooperate fully with 
those providing the services—even if the ofﬁcials opposed the project. This determina-
tion proved fortuitous; as positive results emerged from the project, attitudes among 
resistant staff moved from opposition to acceptance to support. 
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2. Background and Roll-out
The introduction of harm reduction in Moldovan prisons was a joint initiative on the 
part of prison staff and civil society. In 1997 the Department of Penitentiary Institutions, 
in cooperation with the NGO Medical Reforms in Penitentiary Institutions, developed 
a project proposal on prevention of HIV/AIDS and STIs in penitentiary institutions. 
The proposal was funded by the Soros Foundation–Moldova and the Open Society 
Institute’s International Harm Reduction Development Program.12 Its goal was to iden-
tify and initiate appropriate strategies to combat HIV in prisons. While supportive of 
HIV prevention programs, some of the prison ofﬁcials, including Veaceslav Toncoglaz 
(the former deputy director of the Department of Penitentiary Institutions who now 
serves as a consultant to IPP) were initially opposed to the concept of harm reduction: 
“I thought the idea was strange. It sounded as though we’d be accepting and facilitat-
ing the use of drugs in prison.”13
However, Toncoglaz and his colleagues changed their minds after reading the 
results of the NGO’s ﬁrst activity, an anonymous survey conducted among prisoners 
in 1999, the year that HIV ﬁrst became a serious health concern in Moldova. Prisons 
were already heavily affected: The ﬁrst case of HIV infection in the prisons of Moldova 
had been registered in October 1996,14 but a 1999 report stated that a total of 47 HIV-
positive prisoners were in just one prison, Branesti Prison Colony 18. All of them 
were people who inject drugs who had been incarcerated on drug-related charges. 
Meanwhile, HIV-related stigma and discrimination reportedly were rampant, with 
many Moldovans believing it was possible to contract the disease merely by touching 
someone infected with HIV.
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According to the survey, injecting drug use was widespread throughout the 
prison system. Individual needles and syringes were shared by as many as 12 different 
prisoners, and some prisoners were using homemade equipment to inject drugs. The 
survey found that the majority of illegal drugs were smuggled into the prison either 
during visits or by guards and other staff members. The survey also revealed that sex 
between prisoners was common, as was the resulting spread of STIs.15 
Armed with the survey results and information about how and why harm reduc-
tion measures could work, the NGO approached top-level ofﬁcials at the Department 
of Penitentiary Institutions and proposed to initiate a harm reduction pilot project in 
one facility. The survey results helped counter initial skepticism about the project. 
According to Toncoglaz, the survey’s results were important because they “reinforced 
reality. Although prison workers are reluctant to admit it, drugs are in prison...and 
people will use them when they are. We suggested that they now think about reducing 
HIV prevalence and risk.”16 
2.1 Needle Exchange Begins
Criteria for Site Selection
NGO and penitentiary ofﬁcials agreed to implement an initial harm reduction project 
at Branesti prison, a medium and maximum-security prison with a population at that 
time of approximately 1,000 men. They chose that facility because it housed the larg-
est number of prisoners known to be HIV-positive, had the largest number of people 
incarcerated for drug-related offenses, was the prison with the lowest average age 
(mid-20s) and where a signiﬁcant majority were imprisoned for the ﬁrst time. Need 
was greatest in Branesti due to the relatively high levels of HIV and drug use, and 
authorities assumed the project would have a greater opportunity for success because 
the youth and “newness” of the prisoners meant they were less hardened than those 
elsewhere.
Trainings on Safety and Legality
The decision was conveyed to local prison ofﬁcials. The NGO then organized a series 
of trainings with prisoners and with prison staff at all levels. The trainings had two 
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main prongs—to inform and educate about HIV, and to explain the harm reduction 
philosophy and how it would actually work in practice. 
Larisa Pintilei, IPP’s project coordinator, said that most staff and prisoners knew 
little if anything about HIV or hepatitis C, neither how they were transmitted nor how 
infection could be prevented. The only certainty was fear. Prisoners, for example, were 
ignoring, avoiding, and isolating other prisoners they knew or suspected had HIV. 
Prison guards and other staff also avoided those they thought to be HIV-infected. At 
the same, staff were initially almost uniformly hostile to the concept of harm reduc-
tion. They were worried about their personal safety, fearing that they could be acci-
dentally stuck by dirty needles or that prisoners would use the needles as weapons. 
They also believed that distributing safer-injecting materials would encourage illegal 
drug use.
Vitaly Morozan, the interim director of the Branesti prison, was responsible for 
issues related to security and safety at the facility when the project started in 1999. He 
said, “I had never heard of harm reduction. But I did know I was against it. We were 
frightened of giving needles to convicts...we thought it was like giving a knife to them. 
We also thought we were facilitating drug smuggling. Almost everyone felt this way. 
Only the medical unit was supportive, and that’s because they had done some research 
in advance and were more open in general about health issues.”17 
During trainings, the NGO addressed the two main concerns—safety and legal-
ity—head on. Harm reduction would actually improve safety, they said, because it 
would reduce the number of used and potentially contaminated needles in circulation 
and help prevent HIV infections. They added that there would be no change in ofﬁcial 
policy regarding use of illegal drugs. 
Both prisoners and guards were reminded that prisoners found with illegal 
drugs would be disciplined and likely face additional criminal charges. At the same 
time, prison staff were reminded that both Moldovan law and prison policy already 
allowed prisoners to have needles and syringes in their possession.18 After all, such 
items were also used to inject legal substances (such as insulin for diabetics). 
On December 3, 1999, order 115 “On a harm reduction pilot program to be 
implemented in penitentiary institutions” was enacted, authorizing the needle and 
syringe pilot project in the prison. The project was originally run by staff from the 
medical unit. Prisoners were required to visit the medical facility to receive safer-injec-
tion materials, condoms, and all available informational materials. 
16 B A C K G R O U N D  A N D  R O L L - O U T
Project Revision to Increase Reach
Uptake was slow, however; during the approximate ﬁve months that this initial 
distribution system was in place, less than 50 syringes were exchanged and fewer 
than a third of the prisoners known to inject drugs were accessing the project.19 Staff 
from the NGO and the medical unit spoke to numerous prisoners to ﬁnd out why. 
They discovered that many prisoners were reluctant to access the services because they 
did not believe the program was truly anonymous and conﬁdential. Nicolae Bodrug, 
the head of Branesti’s medical unit since 1999, said, “Clients originally thought, when 
staff were running the project, that they would get into trouble if they participated.”20 
Prisoners were concerned that they would be harassed or detained when seeking 
needles and syringes because drug use remained illegal. 
Another obstacle was that medical personnel were not always available when 
prisoners needed them. The project’s services were usually available only when the 
majority of medical staff were present—perhaps eight hours during the day, from 
Monday through Friday. That meant access was nonexistent or limited in the evenings 
and on the weekends.
Peer-based Exchange
NGO staff and Branesti ofﬁcials came up with a plan to change the project. They 
decided that select prisoners should be trained as outreach volunteers to provide ser-
vices to fellow prisoners. According to Dr. Bodrug, “To make the needle exchange 
genuinely anonymous, we recruited eight secondary exchange volunteers to work 
throughout the penal colony. The advantage was a much higher degree of trust and 
conﬁdentiality.” This decision inaugurated stage two of the project.
The peer volunteers provided harm reduction services in four different sites 
within the prison living units (barracks-style accommodations, with 70 or more men 
living and sleeping in the same large room at that time). Two peer volunteers were 
assigned to each site, where they distributed all relevant supplies from a designated 
cabinet or closet near their living space. The project became accessible 24 hours a 
day, seven days a week because clients and direct service providers lived with and near 
each other. Interviews with the peer volunteers revealed that most prisoners access 
the project during the day and evening. One volunteer said: “I need to sleep too, and 
people respect that and come while I am around and awake.” Most importantly, pris-
oners trust that the peer volunteers would never reveal the identity of fellow prisoners 
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accessing the project.21 Volunteers do not register names or last names; they collect 
no information other than writing down the number of syringes and condoms dis-
tributed. This basic data is then given to the medical unit staff supervisor. (See Boxes 
1 and 2 for more information about and observations from volunteers.) The activities 
are carried out in cooperation with the prison physician. The role of the physician is 
to act as project supervisor and as a link between the peer volunteers, prison staff, 
and the NGO staff.
Larisa Pintilei speaks with a volunteer at the prison in Cricova
According to the NGO project coordinator, Larisa Pintilei, after this change was 
made uptake increased dramatically. Soon, 65 to 70 percent of people known to inject 
drugs in the prison were accessing the project through the peer volunteers. Between 
December 1999 and December 2000, the peer volunteers in Branesti exchanged 
2,840 syringes.22 And, she said, nearly 100 percent of all syringes and needles distrib-
uted were returned. Prisoners said they were much more satisﬁed and comfortable 
with the new system.
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2.2 Moving Out of Pilot Phase
As restructured, the project moved out of pilot phase when it was implemented in 
a second prison, Cricova Prison Colony 4, in 2002. By 2008, the NGO was provid-
ing harm reduction services in seven prisons—six men’s prisons and one women’s 
prison. The NGO hopes to move into an eighth prison, but funding constraints have 
prevented further expansion. According to Vladimir Troﬁm, former director general 
of the Department of Penitentiary Institutions, “we would like to cover 100 percent of 
sentenced prisoners.”23 (See Box 3 for more information about the prisons in which 
the NGO operates.)
Decisions about starting a project in a particular institution are made by the 
director general in consultation with the NGO. The NGO ﬁrst does needs assessments 
to determine if services are needed and likely to be used. Among the most important 
criteria are the number and percentage of prisoners convicted on drug-related charges. 
Another key part of the assessments are anonymous surveys conducted among the 
prison population; prisoners are asked about type and frequency of drug use, aware-
ness of HIV, and HIV-related discrimination. 
Once a decision is made, the order to start the project at the institution is issued. 
As it did in Branesti, the NGO then organizes special trainings for staff and prisoners.
For many years, the department and the NGO were reluctant to expand the 
project to pretrial detention facilities (so-called SIZOs or “investigative isolators”). 
Reasons included the overcrowding and often worse overall conditions in these 
facilities and the difﬁculties of implementing peer-based services given the rapid 
turnover of detainees. However, ofﬁcials recognize that risk behaviors occur also in 
pretrial detention facilities and that it may now be more feasible to implement the 
project, or at least some of its components, due to the fact that overcrowding has 
drastically decreased and conditions have improved in pretrial detention facilities. 
As of October 2008, there were a little more than 1,000 detainees in all ﬁve SIZO 
facilities, compared to nearly 3,000 in 2005. According to Troﬁm, introducing the 
project in SIZOs would be much easier now “because there is so much support for 
the project and little resistance because everyone knows the project is good.” He said 
that the department “would be receptive” to advice about expanding the project to these 
pretrial detention facilities.
During a visit to a pretrial detention isolator in Balti in October 2008, the direc-
tor of the institution, Tudor Pascaru, said that he had not been able to participate in 
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BOX 1.
How Volunteers Are Identiﬁed
Prisoners are more than just clients of the harm reduction program in prisons in 
Moldova. Some of them are also at the frontline of service delivery itself. The actual 
supplies—needles, syringes, condoms, alcohol wipes, creams, lubricants, informa-
tion booklets—are distributed by prisoners, who work as volunteers and are spe-
ciﬁcally trained by Innovative Projects in Prison, the NGO that provides the harm 
reduction services. 
NGO staff identiﬁes prisoners who might be willing to participate. The ﬁrst 
step is generally taken during large group meetings prior to the project’s launch at a 
facility. Such meetings and trainings focus on introducing and explaining the project 
to all prisoners. At the conclusion of those meetings, presenters urge interested 
prisoners to consider being volunteers and direct them to indicate interest to the 
prison medical unit director and NGO staff. 
The NGO relies on local staff to play major roles in helping ﬁnd appropriate 
volunteers at the beginning and on an as-needed basis as the project continues. 
NGO personnel note that the medical unit directors interact regularly with the pris-
oners and thus are best placed to recognize suitable candidates. In some cases, this 
means having their own formal or informal criteria. Nataliya Cioran, the director of 
medical services at Rusca prison (interviewed August 23, 2007), said she and her 
colleagues originally approached prisoners they knew were HIV-positive and asked 
them to be involved as volunteers. Their rationale was that such prisoners are more 
inclined to pay close attention to health issues and risk factors and are more likely to 
have direct knowledge, as people with a history of drug use, about behaviors targeted 
by the project. In addition, Cioran said they sought prisoners with “good personali-
ties” who are “open” and “friendly.”
Larisa Pintilei, the NGO’s coordinator, said that only prisoners who have the 
absolute trust of their fellow prisoners can be selected as volunteers—otherwise, the 
project’s services would not be used. In addition, she said that volunteers “must be 
willing to do this work and strictly obey the rules.”
The prisoners do not get paid for their volunteer work. The NGO does, 
however, provide them with “gift bags” on a regular basis, usually once or twice 
a month. The bags generally contain items such as cigarettes, food packages, and 
other hygiene supplies. The provision of these gifts is considered a major incentive 
for participation, given that such items are often in short supply in the facilities. At 
the same time, volunteers are clearly proud of what they are doing. Asked why he had 
been doing this work for more than three years already, one volunteer said: “I do this 
because it is a good thing to do. It helps prevent infections and saves lives.”
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any trainings on HIV and harm reduction delivered by the NGO and therefore knows 
very little about the harm reduction project. “The only thing we do here is provide 
condoms and information leaﬂets, as well as hair cutting implements for people who 
are HIV-positive,” he added.24 He pointed out that drug use is a much rarer occurrence 
in pretrial detention isolators than in prisons, due to the fact that detainees are only 
allowed to receive one monthly short-term visit, which is supervised, and that staff 
who were detected bringing drugs into the institution were dismissed immediately, 
charged with a criminal offence, and sentenced. However, he admitted that drug use 
still occurs and said that “it would be good to have the [harm reduction] project” 
“because it is a positive project” that, as far as he had heard from his colleagues, “has 
many positive outcomes not only for prisoners, but also for staff and ultimately, for 
everyone in Moldovan society.”
This openness reﬂects the fact that, over the past ten years, the project has 
become broadly accepted by the prison department and the Moldovan government 
more broadly, and is viewed as a best practice of sorts. Although the department does 
not fund IPP directly, the organization has always been housed in the department’s 
headquarters in Chisinau, and the government provides that space free of charge. 
Local prisons also provide space to house harm reduction materials, and the prison 
medical directors receive funds from the NGO to allocate part of their working hours 
to the project. 
In 1998–1999, the ﬁrst harm reduction project outside of the Moldovan peniten-
tiary system was initiated in the city of Soroka; by October 2008, harm reduction proj-
ects were operating in 20 locations across the country. Harm reduction is considered 
a major component of the government’s most recent anti-HIV strategy, the National 
Program for Prevention and Control of HIV/AIDS/STIs 2006–2010,25 which stipulates 
that needle exchange and methadone are important elements of a comprehensive 
response and explicitly says that the Ministry of Justice has to “ensure the development 
of activities and measures to prevent and control HIV/AIDS and STIs in penitentiary 
institutions through extending harm reduction programmes and substitution treat-
ment.” The new “Law on HIV/AIDS Infection Prevention” of 2007 also contains an 
article on prevention activities in penitentiary institutions, which stipulates:
“The Ministry of Justice ensures:
a) education and training of staff and inmates, with the purpose to develop 
skills and knowledge on HIV/AIDS prevention, safe and responsible 
behaviors, pre and post voluntary testing [sic], consent for HIV testing;
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b) harm reduction programs, including providing bleach and needle exchange 
supported free of charge and condom distribution in all prisons;
c) access to free-of-charge ARV treatment and treatment for opportunistic 
infections.”26
The government’s efforts are funded partially by the Global Fund to Fight AIDS, 
Tuberculosis and Malaria.27 (See Box 4 for information about the methadone program 
in Moldovan prisons.)
2.3 Overcoming Opposition
Opposition to harm reduction in general, and to distribution of syringes speciﬁcally, 
was initially widespread at all prisons. As at Branesti, most local administrators and 
staff had never heard of such a strategy. Their ﬁrst (and strong) reaction was that it 
ran counter to their long-held primary objective: to uphold laws and punish prisoners 
who violated them. 
For example, Gheorghe Chirila, the director of the women’s prison at Rusca, 
said that opposition was particularly high among security guards in the run-up to the 
project’s launch there in 2003. “One of their responsibilities is to prevent smuggling 
drugs into prison,” Chirila said, “so they asked, ‘Why would we do this? The next thing 
you know, we’ll be giving them drugs.’”28 
In most cases, there was signiﬁcantly less opposition, if any, among directors of 
medical units. The main reason is that prisoners’ health is their primary responsibility. 
They see ﬁrsthand the effects on prisoners of HIV, hepatitis, and STIs, not to mention 
wounds and abscesses related to injecting with dull or unclean needles or substitutes 
such as pens. 
One notable exception was Nataliya Cioran, the director of Rusca’s medical unit. 
She said she was against the project from the very beginning out of concern that access 
to harm reduction services would lead to an increase in overdoses and “crazy” and 
“dangerous” behavior.29 Cioran added that she would not have implemented it in the 
absence of an order to do so. 
When interviewed in 2007, Cioran had completely changed her mind. For one 
thing, she said, her fears were not realized—there had been no increase in overdoses 
or “dangerous” behavior. Instead, there was an increase in knowledge and awareness 
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about HIV among both staff and prisoners and a decline in the number of HIV cases. 
She noted that the safety of both staff and prisoners improved in the wake of those 
key developments.30 
Cioran is not alone in having initially resisted harm reduction before ultimately 
embracing it. Vitaly Morozan, the interim director of Branesti prison, said: “We had 
an order from the director general to initiate the project, so we did it. I’ll admit I was 
still opposed when it began. But over time, I saw that the number of HIV cases was 
decreasing...and that trend has continued.”31
Morozan added that he has since become a willing and constant advocate of the 
project, and he said he tries to use his inﬂuence on its behalf whenever possible: “We 
were the test case because our facility was the ﬁrst one and the project has been here 
the longest. We’re visited by staff from other prisons where the project will be launched. 
They are always apprehensive, even when I discuss the stages of the project and why it 
works well. The most convincing way to reduce their fear and opposition is to have them 
talk to prison staff and prisoners. Just about all of them are in favor of the project.”
Anatolii Vizitiu, head of the medical unit at the Cricova prison, acknowledged the 
importance of positive results and feedback from Branesti. He said he visited Branesti 
and subsequently urged the then-head of his prison to welcome the project. Vizitiu said 
the director and other staff members were swayed by reports from Branesti of, among 
other things, lower rates of hepatitis C and the fact that the project had not led to an 
increase of used injecting materials discarded throughout the facility. He added that he 
tried to focus on practical elements in discussions with both prison staff and prison-
ers. “After all,” Vizitiu said, “they [guards and prisoners] must understand that it’s not 
necessarily advisable but much more reasonable to use new needles and syringes.”32
Similarly, Eduard Timofei, the interim director in Cricova in October 2008, 
said that when he started working at the prison in 2005—three years after the 
project started there—he did not agree with it.33 “But after discussing it with others 
and after receiving more information and training, I understood why it was 
important.” Timofei conﬁrmed that “initially there were some problems, but today all 
staff accept and support the program.” He added: “Staff know why they need to leave 
the project sites alone—if they tried to supervise them and ﬁnd out who exchanges 
injecting equipment, prisoners would soon stop using the project and infection 
rates would go up. Our main purpose must be to prevent the spread of HIV and 
hepatitis C.” When asked about the level of drug use in the prison, he said that 
it was difﬁcult to assess exactly how prevalent drug use is, but highlighted that 
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prisoners who want to use drugs or are dependent on drugs will use them regardless 
of whether clean injecting equipment is available. “The fact that we make needles 
and other injecting equipment available does not increase drug use, it only reduces 
its harms.” However, Timofei said he wished the methadone program was available 
at Cricova prison. Vizitiu, head of the medical unit, agreed, saying that it would 
“reduce drug smuggling and make prisoners who receive treatment with methadone 
less aggressive.” Prisoners in Cricova have already asked to be on methadone 
treatment, Vizitiu added.
Both NGO and prison staff stress the importance of training and education on 
a regular basis, not only when a project begins. That is because turnover of prison-
ers and personnel is high in all prisons. Staff who are new to prisons tend to know 
little about HIV and nothing about harm reduction—and are instinctively suspicious 
of the project. Personnel’s safety concerns vis-à-vis HIV are addressed by providing 
extensive information about transmission and protection. Staff are also generally told 
to act as though all prisoners are HIV-positive. That means, for example, that they 
should always use rubber gloves when in contact with any blood and other bodily 
ﬂuids. Efforts to reassure personnel about their safety tend to reduce not only their 
distrust and fear, but also limit instances of abuse and discrimination based on real 
or perceived HIV status.
Branesti’s director, Morozan, described his approach as follows: “We start off 
by telling all new personnel that they must comply with internal orders. No question. 
And then we get the head of the medical unit to explain how the project works and 
how staff should behave in regard to it. Each staff member, old or new, is encouraged 
to raise any problems or concerns about the project or anything else with his superior. 
Those concerns are usually then brought to the attention of top staff during our weekly 
meeting. Any responses, comments or decisions made are then conveyed to all staff by 
their superiors.” The NGO’s project coordinator Larisa Pintilei added that staff are told 
that the project’s activities are not illegal and that the volunteers are not to be sanctioned 
for the work they do but should be rewarded so that they can do their work, for the 
beneﬁt for prisoners, but also of staff.”34 
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2.4 Current HIV Situation
It has been estimated that there are 77,000 to 116,000 people who inject drugs in 
the Republic of Moldova.35 From 1987 (when the ﬁrst case of HIV in Moldova was 
registered) to January 1, 2007, 2,527 HIV-positive cases were registered, plus 873 in 
Transnistria, for a total of 3,400 cases.36 
As in other countries of the region, the HIV epidemic has been driven primarily 
by injecting drug use. An outbreak of HIV among people who injected drugs occurred 
in 1997 and 1998, when respectively 404 and 408 new HIV cases were detected, of 
which 87.9 and 84.8 percent respectively were among people who injected drugs. In 
recent years, the proportion of people with a history of drug injection among new HIV 
cases has been steadily decreasing, to 38.2 percent in 2006, with a corresponding 
increase of the number of HIV cases contracted sexually. The total number of new 
HIV cases has been steadily and rapidly increasing, from 356 in 2004 to 535 in 2005 
and 616 in 2006.37 
According to Pintilei, the most popular drug among people who inject drugs in 
Moldova (including those incarcerated) is a homemade opiate made from acetylated 
extract of poppy straw. That drug, known locally as shirka, is more common than either 
heroin or amphetamines, both of which are more expensive.
National laws regarding drug use have been relaxed in recent years as part of an 
effort to focus on dealers. Simple drug use is not a crime, but it is an administrative 
offence according to Article 44 of the Administrative Code.38 
Vladimir Tsaranu, the head of medical services in the Department of Penitentiary 
Institutions until 2008, estimated that each year some 400 to 600 individuals newly 
entering the penitentiary system were people who injected drugs. That number 
includes both those convicted and sent to a prison colony and those in pretrial deten-
tion. Tsaranu said that according to ofﬁcial data, about 120 individuals incarcerated 
at the end of 2006 were ofﬁcially identiﬁed as people who used drugs. He added, 
“Multiply by 10 to get the real number.”39
Tsaranu said the number of HIV-positive prisoners ﬂuctuates constantly, but that 
the overall trend had been down. In 2002, he said, there were “maybe” 200 prisoners 
with HIV; ﬁve years later he estimated the total to be about 160. In October 2008, the 
new interim head of medical services, Victor Vovc, estimated the number of HIV-posi-
tive prisoners to be 145.40 He reported that the number of prisoners requesting an HIV 
test is increasing and said that the department was now undertaking a major effort to 
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ensure that “every prisoner who wants an HIV test can get it.”
Until recently, prisoners’ access to HIV testing was limited. Testing campaigns 
were only offered on an occasional basis at each facility, with limited slots available. 
Demand nearly always exceeded supply. One volunteer at Rusca prison, interviewed 
on August 23, 2007, said, “I haven’t had an opportunity to take a blood test for three 
years. I know I have hepatitis C, so it may be that I have HIV also.” Another volunteer 
at Rusca said she wished the Ministry of Health’s AIDS center would visit each prison 
regularly and provide prisoners an opportunity to take an HIV test. According to Oleg 
Borduja, medical director at Cricova Prison Colony 15 at the time of the ﬁrst series of 
interviews in 2007, he was only able to accommodate prisoners’ requests for an HIV 
test—outside of a special testing campaign—if they told him they’d recently engaged 
in risky behavior, such as unprotected sex or using a dirty needle to inject. In such 
cases the prisoner was referred to the penitentiary system’s main hospital at Pruncul. 
Borduja noted that he rarely received such special requests, at least in part because 
prisoners were understandably reluctant to divulge such behavior.41
The penitentiary health system’s inability to provide sufﬁcient HIV testing 
services was indicative of longstanding resource constraints. As of August 2007, for 
example, Vladimir Tsaranu, then head of the penitentiary system’s medical services, 
estimated that the system was receiving “just 40 percent of the funds that we really 
need” to provide an adequate level of care.42 He was hopeful that the situation would 
improve with an infusion of new funds in 2008.
With Global Fund assistance, antiretroviral treatment (ART) ﬁrst became avail-
able in Moldova in 2004. It is now available both outside and inside the penitentiary 
system. According to Vovc, as of October 2008, a cumulative total of 89 prisoners 
had received ART since 2004, with 30 currently on ART. Both he and his predecessor 
said that the department was “able to cover all who want or need ART when they are 
in prison.”
The NGO’s project coordinator Pintilei and other health advocates reported that, 
as in other countries,43 the prevalence of hepatitis C among prisoners is far higher 
than HIV prevalence. In 2006, for example, hepatitis C was detected in nearly two-
thirds (62 percent) of 70 prisoners whose blood was tested at the women’s prison at 
Rusca.44 As of October 2008, however, the high costs of medicines to treat hepatitis C 
precluded their availability in both the penitentiary system and in Moldova in general.45 
Testing for hepatitis C (and hepatitis B) virus was also not available to prisoners; it was, 
one of the “many things we would like to be able to do, but cannot because we do not 
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have sufﬁcient ﬁnancial resources.”46 Caregivers in the separate health systems (for the 
general public and within the penitentiary system) are only able to provide medicines 
to treat hepatitis C symptoms.
2.5 Stafﬁng of Prison Harm Reduction
As of October 2008, there were harm reduction projects in 20 locations all over 
Moldova. The majority were run by NGOs with support from the Global Fund (through 
Soros Foundation–Moldova). The foundation also supported local government ofﬁ-
cials involved in providing harm reduction services. IPP’s project was the only harm 
reduction project in the penitentiary system. The organization has a small number of 
employees working out of its ofﬁces located within the Department of Penitentiary 
Institutions in Chisinau (a coordinator, assistants, and an accountant). 
BOX 2.
Voices of Volunteers at Prisons 
in Branesti and Cricova
The staff at Innovative Projects in Prisons said they greatly value stability and con-
sistency when it comes to actual service delivery. They are particularly proud of their 
success in this regard in Branesti prison, the ﬁrst facility in which the project began 
operating (in 1999). In August 2007, each of the four prisoners overseeing the indi-
vidual harm reduction points in Branesti prison had been volunteers for the project 
for at least two years. One had been volunteering for four years. Their ages ranged 
from 28 to 45. 
Prison ofﬁcials allowed one of the researchers to interview the four volunteers 
in a semi-private manner during a visit to the facility on August 21, 2007. Although 
the interview was conducted jointly, no guards or other prison authorities were in the 
room at the time with the prisoners, the researcher, and two translators. 
During a second visit to prisons and pretrial detention facilities in Moldova 
in October 2008, the second researcher was allowed to interview three volunteers in 
Cricova prison #15 privately, in the presence of only one of the translators. 
Some of the more notable bits of information, observations, and comments 
from the interviews are listed below. To ensure conﬁdentiality, identifying information 
about individual prisoners (including sources of quotes) has not been included:
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• Four of the seven volunteers said they had histories of injecting drug use. They 
acknowledged as well that they had engaged in unsafe behaviors at various 
times in the past, even at times when they knew the risks involved. Sometimes 
they had no choice. According to one volunteer, “I was in a different prison 
for a few years before I came here. The project wasn’t there yet, so it was 
necessary to share needles all the time. We would sharpen them ourselves if 
they went dull.” One of them said he had never used drugs before coming to 
prison and added: “Now I am spending half of my life with people who use 
drugs—the temptation was simply too great and there was nothing else to 
do.” He continued by saying: “The best solution clearly is not to use. When 
someone comes to me for the ﬁrst time and asks for a needle, I usually try to 
talk them out of injecting drugs. But in the end, if they are going to inject, it is 
better if they at least do it with clean equipment.” Another volunteer said that 
“people use or do not use, for a wide number of reasons. The fact that clean 
injecting equipment is available does not make it more likely they will use.”
• “There’s an attitude that everything coming from the authorities must be 
bad,” said a volunteer. “That’s why it’s better that they come to us if they 
want anything. Some of them are our friends...and even those we don’t know 
well aren’t strangers. Usually we’ve seen them, and they’ve seen us, for a long 
time. They trust us. They know we won’t tell anyone that they come to us or 
what they want. If I said anything, I’d get beaten up at the very least.” Another 
volunteer acknowledged that, nevertheless, some prisoners will be reluctant 
to come themselves. “That is why prisoners can come and exchange many 
needles and syringes, not just their own. They can bring the equipment used 
by others, and exchange for them.”
• Some of the volunteers talked about the need to also provide methadone 
treatment, saying that many of the prisoners would like to be on treatment, 
rather than continuing to use. “I know 30 people who would like to be on 
methadone,” said a volunteer.   
• Three of the volunteers—all with histories of injecting drug use—said they 
had tested positive for HIV. All said that they were open about being HIV-
positive in the prison, adding that they rarely if ever experienced any open 
discrimination because of their HIV status. They believe the lack of discrimina-
tion from prison staff and other prisoners is a result of the project’s indirect 
awareness-raising impact. 
One volunteer said his openness about having HIV meant that other prisoners 
listen to him when they visit and he talks about how and why to protect themselves 
when injecting drugs or having sex. He added that he encourages them to get tested 
for HIV if and when possible.
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In addition, the organization contracts the medical directors at the facilities 
where the project operates to oversee the activities of volunteers and outreach workers 
on a daily basis and to ensure sufﬁcient supplies and collect data on a regular basis. 
The medical directors are regularly in contact with the NGO staff by telephone; the 
NGO’s coordinator or an assistant visit each facility at least once a month.
The NGO also hires consultants on an as-needed basis. Most of them are social 
workers who help run trainings on HIV, injecting drug use, and other issues of direct 
interest to the prisoners. 
Finally, the organization works with more than 20 volunteers and outreach work-
ers from among the prisoners. They deliver direct harm reduction services from dedi-
cated points near their living spaces in facilities. Most are thought to be people who 
use or have used drugs, although direct questions about such activities are frowned 
upon due to conﬁdentiality and anonymity considerations. In some facilities, volun-
teers have been involved for up to four years. (See Box 1 for information about how 
volunteers are selected, and Box 2 about volunteers’ viewpoints.) 
It is worth noting that there are numerous other NGOs that provide social sup-
port to prisoners with TB and other services such as education assistance, legal assis-
tance, and religious guidance. Foreign as well as local NGOs are involved in such 
efforts. For example, during research for this publication, one of the authors visited 
one prison (Cricova #15) the same day that a group of 60 doctors were also visiting. 
They were members of a U.S. faith-based organization that provides free eye examina-
tions to all prisoners who want them. The organization reportedly arranges such visits 
two or three times a year.47
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3.  Service Provision
3.1 Peer Outreach
As noted previously, the NGO’s project is structured so that harm reduction materi-
als are provided by prison outreach volunteers to other prisoners on a peer-to-peer 
basis, allowing clients to participate without fear of disclosure to prison authori-
ties. Prisoners trust each other (within reason) more than they do prison personnel, 
regardless of position or department. Also, a volunteer who “rats” on another 
prisoner—by, say, disclosing that he or she exchanges needles or syringes—risks 
being beaten if found out.
The NGO and prison medical staff collaborate in identifying potential volun-
teers and training them (see Box 1). There is no formal monitoring system in place 
for volunteers. However, the heads of prison medical units, who are paid by the NGO 
to oversee the individual projects, often ﬁnd indirect ways to determine the quality of 
direct service delivery. At Cricova prison #4, for example, Anatol Vizitiu, the head of 
medical services, said he occasionally discusses the project with prisoners in private 
and tells them he is collecting conﬁdential observations. He asks prisoners about 
their impression of the project and its volunteers, with a goal of determining whether 
clients are getting what they need and in the most convenient and appropriate manner 
possible. Vizitiu also makes a point to ask a number of prisoners if the volunteers are 
providing information about HIV and safer-injection practices.48
The number of harm reduction points staffed by volunteers ranges from two 
to four, depending on the prison. The points are located near the volunteers’ living 
spaces, which might be as large as a room with up to 100 other prisoners or as small 
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as one room with just two beds. The supplies are stored in small metal or wooden 
cabinets lined with shelves. Each cabinet has a door that is kept closed when supplies 
are not being distributed. The cabinets are locked only in Rusca, the women’s prison, 
where only the volunteer has the key to open her cabinet. The cabinets are locked there 
to prevent theft, according to the medical director.49 Volunteers interviewed elsewhere 
said they and the medical staff had determined that locking the cabinets was a disin-
centive to project participation because it indicated that other prisoners could not be 
trusted. None of the volunteers interviewed in the men’s prison colonies said they had 
ever seen evidence of theft. One added simply, “I’m always here anyway.” Another said: 
“Our internal rules are very strict. Nobody touches anything unless I am here.”
Volunteers provide information about HIV and health in addition to supplies
31H A R M  R E D U C T I O N  I N  P R I S O N :  T H E  M O L D O V A  M O D E L
BOX 3.
Detention Facilities in Moldova
There are 17 facilities within Moldova’s penitentiary system: eight prisons, a prison 
hospital, a detention center for juveniles, ﬁve pretrial detention facilities; and two 
“suspended” (i.e., not currently open) prisons. As of October 30, 2008, there were 
6,986 prisoners in the eight prisons, and “a little more than 1,000 detainees”i in the 
ﬁve investigative isolator (pretrial detention) facilities. This represents a substantial 
decrease from recent years, as shown below.ii 
Recent prison population trend 
Year Prison population total, including pretrial detaineesiii
1992 10,258
1995 9,781
1998 10,521
2001 10,037
2004 10,591
The NGO that provides harm reduction services and trainings has been active 
in six prisons for several years and more recently began working in a seventh prison. 
Once funding will allow it, the NGO plans to expand the project to the last prison 
for adults. After that, the next challenge will be to expand it to pretrial detention 
facilities.
Research conducted in August 2007 included site visits to ﬁve of the six pris-
ons in which the project was operating at the time. In October 2008 site visits were 
undertaken to two of the prisons (Cricova #4 and Cricova #15) also visited in 2007, 
and to an investigative isolator facility. 
Four of the ﬁve prisons visited are classiﬁed as “semi-enclosed”, which means 
that prisoners are generally not locked in cells and can walk around the facility on 
their own. The ﬁfth prison, Cricova #15, is a “closed” facility in which prisoners face 
far greater restrictions on activities. According to Ruslan Galupa, director of regime 
and surveillance at that facility (interviewed August 24, 2007), it is for prisoners 
convicted numerous times as well as those who have committed “exceptionally seri-
ous” crimes such as murder.
Snapshots of the ﬁve prisons visited are included below:
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1) Branesti #18
 • Location: 50 km (31 miles) from Chisinau
 • Number of prisoners (all men): about 1,000 (August 2007); 521 (October 30, 
2008)
 • Type of facility: “semi-enclosed” 
 • Year harm reduction project began: 1999
 • Number of separate harm reduction points: 4
2) Cricova #4
 • Location: 20 km (12 miles) from Chisinau
 • Number of prisoners (all men): about 1,000 (August 2007); 802 (October 30, 
2008)
 • Type of facility: “semi-enclosed” 
 • Year harm reduction project began: 2002
 • Number of separate harm reduction points: 3
3) Pruncul #9
 • Location: outskirts of Chisinau
 • Type of facility: “semi-enclosed”
 • Number of prisoners (all men): 675 (August 2007) 
 • Year harm reduction project began: 2005 
 • Number of separate harm reduction points: 2 
4) Rusca #7
 • Location: 60 km (37 miles) from Chisinau
 • Type of facility: “semi-enclosed”
 • Number of prisoners (all women): 280 (August 2007) 
 • Year harm reduction project began: 2003
 • Number of separate harm reduction points: 3
5) Cricova #15
 • Location: 20 km (12 miles) from Chisinau
 • Type of facility: “closed” 
 • Number of prisoners (all men): 571 (August 2007)
 • Year harm reduction project began: 2005
 • Number of separate harm reduction points: 2 
About the Facilities
Five of the six prisons in which the project operated in August 2007 were for male 
prisoners. All six differ in how prisoners are housed. In some, the majority of prison-
ers sleep in large, communal rooms with up to 100 individual cots, often crammed 
close together (although the recent decrease in the number of prisoners has resulted 
in less overcrowded situations particularly in these communal rooms). Each prison 
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also tends to have a few smaller rooms with beds for two to 15 prisoners. Prisoners 
typically are not segregated by reason for incarceration or length of sentence.iv HIV-
positive prisoners are not segregated either, unless they have active TB, in which case 
they are required (as are all prisoners with active TB) to be treated in the penitentiary 
system’s main hospital. However, in one of the prisons visited, HIV-positive pris-
oners did live together in one room, allegedly because they preferred this to being 
placed with other prisoners.v 
All ﬁve prisons have some sort of work program for prisoners. Facility admin-
istrators and staff interviewed in August 2007 said that work is voluntary—prisoners 
can choose to participate in work programs. In most cases, prisoners who wish to 
participate are required to apply for the jobs, many of which (for all but those in the 
“closed” prison) are not on facilities’ premises. Among the jobs available are: shoe-
making, construction, wood-carving, and agricultural work (i.e., planting and picking 
crops). Prison ofﬁcials stressed that prisoners are paid for their work, with the money 
deposited into an individual account. As observed during site visits in August 2007, 
participation in work programs in some facilities was as high as 50 percent of all 
prisoners. According to then Director General Vladimir Troﬁm, “prisoners are very 
interested in working because of recent changes to the legislation—now one day of 
work counts for three days of imprisonment and the salary is attractive.”vi Troﬁm 
spoke with passion about the increased efforts to offer more work and training 
opportunities, and more interesting work, to prisoners. He said that, as of October 
30, 2008, there was work for almost 4,000 prisoners.
The investigative isolator facility visited in October 2008 was facility #11 in 
Balti, Moldova’s oldest institution, built in 1812. It has three sectors (closed, semi-
closed, and open), with a total of 409 detainees as of October 31, 2008, including 
16 women and eight minors (compared to 1,000 male, 60 female, and 50 minors 
on average in 2002).  
Notes
i. Interview with Vladimir Troﬁm, October 30, 2008.
ii. International Centre for Prison Studies. Prison Brief for Moldova. London: King’s 
 College, 2008. At http://www.kcl.ac.uk/depsta/law/research/icps/worldbrief/wpb_country.
 php?country=155 (accessed on January 16, 2009).
iii. Data from Prison Brief Moldova, supra, note 1.
iv. One important exception was noted in Branesti prison. A separate living space there was 
 reserved for “lower hierarchy” prisoners. 
v. Interview in Cricova #15, October 30, 2008.
vi. Interview with Vladimir Troﬁm, October 30, 2008.
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Some volunteers personalize their cabinets by displaying brochures, booklets, or 
posters on adjacent walls or on top of their cabinets. Every cabinet contains needles, 
syringes of varying sizes, condoms, alcohol wipes, basic medicines such as troxevasin 
(for collapsed veins), and booklets and pamphlets containing information about HIV 
and safer-injection practices. Until 2007 (when this practice was discontinued because 
of lack of funding) razor blades were also provided, since sharing of razor blades is a 
common occurrence in prisons in low- and middle-income countries, and puts prison-
ers at risk of contracting blood-borne infections.50 In addition to reducing the risk of 
blood-borne infections—in particular, hepatitis C—there is another important reason 
to make razor blades available through harm reduction projects: every prisoner has 
an incentive to visit the volunteers, not only those engaging in illegal or forbidden 
and stigmatized behaviors. This normalizes the project and makes it much easier for 
those who might otherwise avoid the visit for fear of being identiﬁed as engaging in 
such behaviors. 
Every 10 days or so, the volunteers bring a bucket full of used materials to 
the medical unit director. They sign a form on which is noted the number of used 
syringes and needles in the bucket. Volunteers receive clean syringes and needles in 
return. However, they may request and receive larger or smaller amounts depending 
on demand and trends. Also, medical directors are instructed to be open to providing 
additional needles and syringes to volunteers should they run out suddenly before they 
are scheduled to return the used supplies. Used syringes and needles are incinerated 
on the facilities’ grounds. 
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Used syringes are collected in disinfectant liquid and then incinerated
During their regular visits to the medical unit with the used syringes and nee-
dles, volunteers also provide information as to the number and type of other materials 
distributed, including condoms, medicines, alcohol wipes, booklets, etc. Their supply 
of such materials is replenished as needed, based primarily on demand and usage 
trends.
It is important to note that the only information exchanged during these inter-
actions refers to the number of needles, syringes, condoms, booklets, etc. that have 
been distributed. No names, codes or other data are provided. Medical directors subse-
quently provide the data to the NGO, which uses it to help plan future supply orders. 
The NGO also adds the data to regular reports it shares with funders and penitentiary 
system ofﬁcials. 
Some volunteers and local prison staff were able to provide information and 
estimates regarding clients served and materials distributed. A sampling of responses 
is noted below:
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• Average number of clients (includes prisoners who do not need needles 
or syringes, but may want condoms or information booklets only):
  — Cricova #4 (August 20, 2007): about 10 per day (as per volunteer)
  — Branesti (August 21, 2007): four volunteers estimated 50 to 60 per 
day, 30 per day, 70 to 80 per day, and 40 to 50 per day, respectively
  — Pruncul (August 22, 2007): 700 a month (as per volunteer)
  — Cricova #15 (October 30, 2008): one of the volunteers estimated that 
he had 15 to 20 per day, while another estimated he had up to 40, 
“but rarely less than 30.”
• Average number of supplies distributed:
  — Branesti (August 21, 2007): 800 needles and syringes each through-
out the facility, on weekly basis (as per volunteers)
  — Pruncul (August 22, 2007): 600 syringes and 600 condoms distrib-
uted each month at one point (as per volunteer)
  — Rusca (August 23, 2007): 1,100 needles exchanged in July 2007 
throughout the entire facility (as per medical unit director)
  — Cricova #15: two volunteers estimated 400 to 500 syringes and nee-
dles a month, and 200 syringes and needles a month, respectively. 
One volunteer estimated he distributed 400 condoms a month, 
while the other said he distributed perhaps 50 to 60 a month.
All points offer a wide range of syringe sizes. The most popular, according to 
Larisa Pintilei and volunteers asked, are 1, 2, and 5cc. Providing a wide range of syringe 
sizes is important since evaluation of a needle and syringe program in a prison in 
Germany showed that many prisoners did not access that program because it did not 
provide the sizes that were most in demand.51
Separately, Pintilei said that, as of August 2007, on average the NGO distributed 
a total of 7,600 needles and syringes each month across all six prison colonies. The 
number of condoms distributed ranged from 1,500 to 3,000 a month, she said. Pintilei 
noted signiﬁcant differences among prisons, with demand being highest in Branesti 
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(where prisoners are younger and more likely to be incarcerated for drug use-related 
convictions). She also said that demand for syringes in general tended to be higher in 
spring and summer.52 The total number of needles and syringes exchanged in prisons 
in Moldova increased from 3,650 in 2000/2001 when the project was running only 
in Branesti prison to 84,280 in 2006/2007. 
3.2 Training
Training has been a major part of the NGO’s work from the very beginning, as noted 
previously. The NGO offers training on a regular basis in all of the facilities in which 
it operates, with the primary focus being on new prisoners and prison personnel. 
The trainings address all aspects of HIV, including transmission and prevention, as 
well as other relevant conditions such as hepatitis and STIs. Presenters then explain 
how the harm reduction project works and what it intends to achieve. They also seek 
to reinforce the conﬁdential aspects of the project; to encourage prisoners to utilize 
the services; and to explain relevant legal and policy issues, such as the fact that the 
volunteers do not engage in any illegal activity by distributing needles and syringes 
and that prisoners can legally possess injecting equipment but can still be charged if 
found in possession of an illegal substance.
Trainings are conducted by consultants as well as by NGO staff. For the ﬁrst 
several years, up to six trainings a month were held at each facility. While funding 
constraints have forced the NGO to reduce the number of trainings, they are consid-
ered vital by both the NGO and prison staff. As observed by Gheorghe Chirila, the 
director of Rusca prison, “It’s much better to work with those who are well-informed, 
both staff and prisoners.”53 
3.3 Budget
In November 2008, Pintilei provided the overall budget for the NGO’s activities in 
seven penitentiaries.54 Of an overall annual budget of US$37,541, $12,650 went to staff 
salaries; $9,240 to condoms, syringes, and other harm reduction supplies; $2,244 
to administrative expenses; and $13,407 to “other expenses” of the project, of which 
$2,200 were for rewards to volunteers. 
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4. Project Evaluation
In some ways it is difﬁcult to gauge the impact of these harm reduction efforts. Prisons 
are not static environments; prisoners move in and out on a regular basis, hampering 
efforts to collect statistically relevant information. In the absence of rigorous statistics, 
it is tempting to view anecdotal evidence and perceived general trends as sufﬁcient 
basis on which to base evaluations. That temptation should be resisted in the interests 
of accuracy and project replicability. When asked, Pintilei acknowledged that the NGO 
and prison administration had collected much persuasive data over the years, demon-
strating the positive impact of the project. “Every time we start the program in a new 
prison, we see a reduction in new cases of HIV and hepatitis B and C. The main goal 
of the project is achieved: in the prisons where the project is run, every prisoner has 
access to sterile injection equipment, condoms, information materials, HIV testing, 
ART, or methadone. Discrimination against HIV-positive prisoners is almost absent 
in the Moldovan prisons. At the same time, we know there are limitations of our data 
and that we cannot scientiﬁcally prove that the reduction in infections is due to the 
project. We would be interested in getting funding and assistance for a more rigorous 
evaluation.”55
A review of studies and other available information on all needle and syringe 
programs in prisons worldwide noted that randomized clinical trials, often regarded as 
the gold standard for tests of efﬁcacy, would be difﬁcult, if not impossible, to conduct 
in prisons.56 Indeed, in all countries in which studies on needle and syringe programs 
in prisons have been undertaken, ethical committees rejected proposals to under-
take randomized clinical trials, ﬁnding that—in light of the large body of evidence of 
the effectiveness of needle and syringe programs outside prison and other factors—
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a comparison of outcomes among comparable groups of prisoners with and without 
access to needle and syringe programs would be unethical. The review of studies 
found that, “[w]ith the exception of one prison in which sharing continued because of 
insufﬁcient supply with needles and syringes, all available evaluations have shown that 
sharing of injecting equipment either ceased after implementation of the NSP [needle 
and syringe program], or signiﬁcantly dropped.”57 It continued by saying:
No new cases of HIV were reported in any evaluation. In ﬁve of the 
six prisons in which blood tests were performed for HIV or hepatitis 
infection, no seroconversion was observed, and self-reports in other 
prisons also indicated no new cases of infection. In another prison in 
which the incidence of HIV, HBV, and HCV was determined through 
repeated testing, no HIV and HBV seroconversions were observed, 
but four HCV seroconversions, one of which had deﬁnitely occurred 
in prison.58
The review further noted: 
In addition, there is evidence of ancillary beneﬁts associated with 
the implementation of NSPs, including: a reduction of overdose 
incidents and deaths; facilitation of greater prisoner contact with 
drug treatment programmes; reduction in abscesses, improved 
relationships between prisoners and staff, and increased awareness of 
infection transmission and risk behaviours; and increased staff safety, 
because accidental injuries from hidden injecting equipment during 
cell searches decreased.59
Finally, it found that “[t]here have been no reports of syringes having been used 
as weapons in any prison with an operating NSP” and that “[t]he availability of sterile 
injecting equipment has not resulted in an increased number of prisoners inject-
ing drugs, an increase in overall drug use or an increase in the amount of drugs in 
prisons.”60
Such positive results have been documented, although sometimes less rigor-
ously, also in prisons in Moldova. 
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Declines in HIV Cases
Several seroprevalence studies undertaken in prisons in Moldova since the project 
began have shown that the percentage of prisoners living with HIV has declined over 
the years. In addition, Pintilei and the medical directors in the prisons in which the 
project has been active report that the number of new cases of HIV, hepatitis C, and 
STIs has also been declining. 
• Branesti #18: Nicolai Bodrug, the head of the prison’s medical unit, cited 
several blood testing campaigns conducted since the project began in 
Branesti colony in 1999. He said that one early campaign indicated that 
“one of every nine” prisoners had HIV, but that the most recent campaign 
indicated that just “one of every 17 prisoners” was HIV-positive.61
• Pruncul #9: Igor Jalba, the head of the prison’s medical unit, said a test-
ing campaign conducted in 2005, the year the project was initiated in his 
colony, found eight HIV cases among 128 prisoners tested. A year later, 
no HIV cases were found among 35 prisoners tested. Jalba added that ﬁve 
cases of syphilis were found among the 35 prisoners tested in 2006. He 
said he did not have comparative data on hand for 2005, but that “there 
were deﬁnitely more cases [of syphilis] then.”62
• Rusca #7: According to the prison’s director, Gheorghe Chirila, his facility 
had the highest percentage of HIV-positive prisoners in the entire sys-
tem—12 percent, or 24 prisoners—when the project began in 2003. That 
ﬁgure was based on blood tests conducted, voluntarily he said, among 
all prisoners. Two years later, the total number of HIV-positive prisoners 
was 11. That ﬁgure was also based on a testing campaign that reached all 
prisoners, according to Chirila.63
• Cricova #15: Oleg Borduja, then head of the prison’s medical unit, said a 
testing campaign in 2005 revealed 16 HIV cases. Two years later, he said, 
just seven cases were found in another testing campaign. Borduja said 
that each testing campaign reached about one-tenth of all prisoners at the 
time.64
While such declines could be due to a number of factors, the vast majority 
of prisoners who inject drugs in Moldovan prisons report never sharing injecting 
equipment.65 Coupled with evidence of extensive injecting drug use in prisons, and 
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data showing that the number of people who inject drugs in the community outside 
prisons who contract HIV has continued to increase in recent years,66 evidence sug-
gests that the harm reduction program has been successful in its primary goal of 
limiting risk behaviors and helping prisoners protect themselves from harm.
Equally important, consistent with the experience in other prison systems with 
needle and syringe programs, penitentiary system staff point out that the project has 
had no negative consequences, and prisoners, prison staff, and medical personnel 
report positive impacts. 
Decrease in Discarded Injection Paraphernalia
Chirila, the director of the Rusca prison, said that since the project began in 2003, 
no used needles were found on the grounds of his facility. As a result, he said, the 
environment was safer for both prisoners and staff.67
Prisoner Empowerment
Chirila said the project had helped motivate prisoners to focus on and take greater 
care of their own health. One reason, he claimed, was that prisoners were more 
inclined to believe that the administration was willing and able to support and help 
them. According to Chirila, “They now have the information they need to ask for and 
demand help” in protecting their health in general, not just in regard to drug use and 
HIV.68Chirila’s observations were echoed by Oleg Borduja, then medical director at 
Cricova prison #15. He noted that as “guards and prisoners learn more about HIV, 
they are more likely to take measures to protect themselves.”69
Reduction in STIs Among Prisoners
According to Borduja, “We’ve observed, from our medical records, that the number of 
cases of syphilis and other STIs, including trichomoniasis, has decreased.” He attrib-
uted such trends to the availability of condoms through the harm reduction project.70
Reduced Safety Risks for Prison Personnel
Ruslan Galupa, the head of security services at Cricova prison #15, said the project’s 
implementation had helped improve the safety and security of guards and other prison 
staff. He cited three main reasons:71 
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• Prior to the project’s initiation, most staff knew nothing about HIV. 
Project-related training sessions have given personnel extensive infor-
mation regarding HIV transmission and protection. Such knowledge 
has helped them make smarter decisions and reduced fear based on the 
unknown.
• Guards come across far fewer discarded needles and syringes. And those 
that they do ﬁnd are less likely to contain HIV or hepatitis C because, given 
prisoners’ easy and consistent access to clean needles, they have probably 
been used by just one person.
• Before the project began, prisoners who injected drugs were often forced 
to reuse and share injecting supplies. They frequently hid needles and 
syringes in places such as their clothes or under their beds. That greatly 
increased the risk of needle sticks and other harms for prison staff who 
searched prisoners and/or their living areas. With the advent of the proj-
ect, however, prisoners can dispose of their used needles relatively quickly 
and safely because they know they can get new ones if needed. Prison staff 
are at a much lesser risk of harming themselves as a result. 
It should be noted that, unlike the needle and syringe programs in prisons in 
Western Europe,72 the project in Moldova does not provide plastic storage cases to 
prisoners for disposing injecting equipment. There are no regulations requiring pris-
oners to store their injecting equipment in such cases, or in particular locations in 
their living quarters. Initially, the decision against providing plastic cases was made on 
economic grounds. Later, it became clear that the projects were working well and safely 
without such storage cases and it was therefore decided they were unnecessary.73
Reduction in HIV-related Stigma and Discrimination
Two respondents—Oleg Borduja in Cricova and Gheorghe Chirila in Rusca—said 
the project’s implementation had helped reduce stigma and discrimination by both 
prison staff and prisoners toward prisoners known or thought to be HIV-positive. 
The reason, they both claimed, was improved knowledge and awareness. As a result 
of trainings and extensive access to booklets and other informational materials, 
prisoners and staff are more likely to know how and why HIV can actually be 
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transmitted—and that, for example, it cannot be contracted merely by touching some-
one or sharing utensils. 
Borduja said that HIV-positive prisoners in his facility often were ignored and 
isolated by other prisoners. He added that prisoners with HIV had become far more 
integrated into the community since 2005, when the project was implemented. 
Borduja also said that the clear reduction in HIV-related stigma and discrimina-
tion pointed to the need for training and education to be conducted on a regular basis. 
That was the only way for the beneﬁts to continue, he said, given that new prisoners 
were arriving constantly and new guards were hired almost as frequently. Most new-
comers, he observed, were inclined to discriminate and stigmatize on the basis of real 
or perceived HIV status because they are mostly ignorant about the disease. 
Inﬂuence on society in general
Pintilei noted that the project’s awareness-raising elements cannot help but have a 
positive impact on society in general.74 “Prisoners are released regularly. Those with 
awareness of HIV and an appreciation of harm reduction are more likely to continue 
taking measures to protect their own health and the health of those around them even 
outside of prison walls. Their examples and explanations have a ripple effect among 
their family, friends, and drug-use and sex partners. Signiﬁcant beneﬁts accrue not 
just to their individual health, but to public health in general.” 
The beneﬁts to public health are likely to be magniﬁed, according to Pintilei, 
because prisons are disproportionately high risk environments for HIV, hepatitis C, 
TB, and STIs. Reducing the prevalence of such diseases in prisons is an important step 
toward reducing their prevalence throughout the general population.
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5. Challenges 
The NGO and its allies have faced, and continue to face, numerous challenges to their 
efforts to provide consistent, reliable, and comprehensive harm reduction services to 
as many prisoners as possible. They have been able to identify solutions to address 
some of them, especially those related speciﬁcally to the project’s structure. The more 
intractable obstacles tend to stem from one main problem: a chronic lack of sufﬁcient 
funds at both the NGO and its government sector partners. 
Some of the most notable past, present, and ongoing challenges are listed in 
this section. All individuals involved in the project agreed that the challenge discussed 
ﬁrst, in Section 5.1, has proved to be the most persistent and thus the most important 
to address appropriately.
5.1 Resistance from Prison Staff 
As noted throughout this report, prison personnel at all levels are nearly always 
opposed to the project at ﬁrst. This obstacle has been approached via a dual strategy 
of “command and education.” The command element is simple: An order to start 
the project is issued to heads of individual prisons and their medical departments’ 
supervisors. They have had no choice but to act on the department’s order and allow 
the project to operate in their facilities. 
However, Troﬁm, the department’s former director general, emphasized that 
such a command must be accompanied by a clear and immediate commitment to edu-
cation. Trainings for all prison staff, from directors to guards, must focus on raising 
46 C H A L L E N G E S
awareness about HIV and other relevant health issues. The project must be explained 
both in concept as well as in execution. Troﬁm observed from experience that “guards 
want to know exactly how to act and respond in individual situations...such as what 
they should do if they see a needle or a syringe on a prisoner.”75 
He added that both prison staff and prisoners must be aware of and understand 
the speciﬁc legal issues and contexts as well. Prison staff, he said, are particularly reas-
sured when “we make it clear that there is a disciplinary element. We tell prisoners 
that in exchange for the help we offer them, they must abide by all relevant rules, poli-
cies, and regulations. For example, they must know that if caught with illegal drugs, 
they will be disciplined...that’s the law. This is important for the guards to understand 
as well because it helps them see that they aren’t giving everything away by accepting 
the harm reduction project and helping it operate smoothly.”76
Another key step in overcoming staff opposition, according to Troﬁm, has been to 
provide them with speciﬁc health safety information. He said, “Trainers explain the type 
and scope of risks to staff, regarding HIV in particular. Guards are much more relaxed 
and open once they recognize such risks are minimal if they take basic precautions.” 
One key policy that has been effective, he added, is to “make it clear that all staff should 
adopt a rule of treating every prisoner as if he or she is HIV-positive. That doesn’t mean 
be afraid of them or discriminate against them. It just means that you should, for 
example, wear gloves when patting down prisoners and when touching bodily ﬂuids. 
We remind them that they should always do so in a respectful manner.”77
Troﬁm reinforced the importance of providing training on an ongoing and regu-
lar basis, not just prior to the project’s initiation in a speciﬁc facility: “Training has to 
continue all the time because there are always new people coming into institutions, 
both new prisoners and new guards. It’s rare that any of them have ever heard of harm 
reduction, so they are naturally suspicious. The cycle repeats itself, with those who are 
trained sufﬁciently nearly always accepting the project.”78 
The NGO’s coordinator, Larisa Pintilei, was adamant in echoing Troﬁm’s com-
ments on the need for training to be ongoing. “Regular training,” she said, “is vital 
to limit potential problems and to ensure the projects’ effectiveness. There have been 
instances when guards’ personal attitudes have been negative toward the project. They 
will comply with orders, but not always happily. They won’t go out of their way to help 
the project proceed effectively, as they should.”79
Pintilei cited one case when a guard seized a volunteer after he left the medical 
unit with new supplies for his harm reduction point. The guard reportedly locked the 
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volunteer in an isolated cell for several hours. He was released only after the head of 
the medical unit was informed. When questioned, the guard, who was newly hired, 
said he did not know about the project and assumed the volunteer was involved in 
illegal activities.
Pintilei added that such instances are rare. However, she said, they would likely 
be more common in the absence of extensive and ongoing training for both staff and 
prisoners. She said she was increasingly concerned about the impact of recent cut-
backs in trainings, due to funding constraints, on the project’s ability to provide both 
staff and prisoners with as much information and support as possible.
When ﬁnancing was better, Pintilei said, “we had up to four trainings a month, 
maybe, in each facility—two for prisoners and two for employees.” With funding short-
falls forcing decreases in training, some of the prisoners have been complaining about 
the lack of specialized support. “The state-provided psychologists and social workers in 
prison tend to focus on general issues regarding health and well-being, but the project 
psychologists and social workers have always focused on issues speciﬁcally related to 
drug use and HIV,” she added.80
One casualty of funding problems has been the NGO’s service focusing on pre-
paring drug dependent and HIV-positive prisoners for release. According to Pintilei, 
“the consultants offered advice on how to establish social connections with relatives, to 
interact with others, ﬁnd housing, and make connections with harm reduction projects 
outside if necessary. We invited all prisoners to participate, but indicated that the ser-
vices would be particularly useful for people who use drugs and people with HIV.”81
5.2 Funding Constraints
As noted, funding levels have been insufﬁcient to provide all services and all the train-
ings that are needed. Liliana Gherman at Soros Foundation-Moldova acknowledged 
that it is “difﬁcult to raise funds in and for Moldova” in addition to the funds pro-
vided by the Global Fund.82 She noted that the Department of Penitentiary Institutions, 
despite a severe lack of funding for its activities, is co-funding harm reduction activi-
ties and has made a US$5,000 contribution. In 2008, Soros Foundation–Moldova 
provided some additional funds of its own to IPP for a training for penitentiary staff, 
and funded two evaluations of the substitution treatment program in Moldova, includ-
ing in prisons.83 
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According to Pintilei, the budget deﬁcit for 2008 amounted to approximately 
$14,000.
One outcome of the funding deﬁcit is that the NGO was forced to put on hold 
plans to expand the project to additional prisons. Pintilei added that in the meantime, 
“We never will stop the project...although we do worry about having to decrease vol-
ume, in terms of some services.” 
The availability of “core” materials—condoms, syringes, needles, and other safer-
injection items—has not changed, though it will be important to ensure that razor 
blades will become available to prisoners again soon. 
The NGO regularly faces requests and pleas for additional assistance from both 
prisoners and prison ofﬁcials, including for nutritional supplies for HIV-positive 
prisoners, especially those who do not receive supplementary food from relatives or 
friends on the outside.
Igor Jalba, the head of the medical unit at Pruncul prison, said his facility was 
in great need of additional vitamins, razor blades, and medicines to treat liver condi-
tions. He said that budget cuts in the penitentiary health system had greatly reduced 
the quantity of such medicines, which were commonly needed by prisoners due to the 
high prevalence of hepatitis C.84
Expansion to Pretrial Detention Facilities
Additional funding will also be needed to expand the project to pretrial detention 
facilities. This will raise additional challenges, as the project relies on volunteers who 
often work for it for years. Rapid turnover of prisoners in pretrial detention facilities, 
as well as the particular conditions in these facilities, mean that the project will have to 
devise innovative ways of delivering its services. Despite some initial reservations, both 
Troﬁm and Pintilei were open to expanding the project to pretrial detention facilities, 
provided additional funding could be secured. In particular, they acknowledged that 
some of the project’s activities, such as providing trainings for staff and detainees and 
undertaking a survey of HIV prevalence, risk behaviors, and detainees’ knowledge, 
attitudes and needs with regard to HIV and other infectious diseases, could and should 
start soon. As Troﬁm said, “now is a good time to start this,” and this was conﬁrmed 
by the fact that the director of the pretrial detention facility in Beltsi, Tudor Pascaru, 
said that he would welcome the project’s activities in his facility.
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Limitations on Data Collection
As noted by the head of the medical unit in Branesti, Nicolae Bodrug, one negative 
element of the peer-to-peer approach is that it limits project administrators’ ability to 
collect certain kinds of data. He noted, for example, that the strict conﬁdentiality policy 
precludes more precise determination of the number of people who inject drugs in a 
prison. “We can only make a slight estimation based on the number of syringes dis-
tributed,” he said. Bodrug added, however, that such a limitation should be accepted 
as is. The important thing, he said, is to “diminish risk and improve prisoners’ health, 
not to collect exact information as to the number of prisoners who use drugs.”85
Expanding Methadone in Prisons and Pretrial Detention Facilities
As discussed in greater detail in Box 4, methadone has more recently become available 
in some prisons in Moldova, complementing the harm reduction services provided 
and offering another important alternative to prisoners with severe opioid dependence 
to decrease their risk of contracting HIV, hepatitis C, and other infections, and to 
achieve other positive outcomes. International recommendations urge prison systems 
to make both needle and syringe programs and other harm reduction interventions, 
including methadone, available to all prisoners in need.86 Those interviewed for this 
study agreed that greater access to methadone in prisons in Moldova and outside is 
needed, and that increasing the number of prisoners on methadone would beneﬁt not 
only individual prisoners, but also lead to a better environment in the prisons. Another 
challenge will be to ensure that people on methadone in the community can continue 
treatment in pretrial detention facilities. Because of the many positive developments 
in the Department of Penitentiary Institutions in recent years, and the great leadership 
provided by its senior staff, now would be a good time to plan for the needed expansion 
and scale up, and to secure the necessary funding. 
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BOX 4. 
Methadone Treatment for Drug-dependent Prisoners
Moldova initiated methadone treatment in October 2004 and was the ﬁrst among 
the countries of the former Soviet Union to introduce methadone in penitentiary 
institutions in July 2005.
The beneﬁts of providing methadone treatment (also known as opiate substi-
tution treatment or OST) in prisons have been well documented.
i
 International orga-
nizations, including the United Nations Ofﬁce of Drugs and Crime (UNODC), the 
World Health Organization, and UNAIDS have recommended that “[p]rison authori-
ties in countries in which OST is available in the community should introduce OST 
programmes urgently and expand implementation to scale as soon as possible.”
ii
According to Victor Vovc the recently appointed head of medical services in 
the national Department of Penitentiary Institutions, on October 1, 2008, 40 pris-
oners were enrolled in methadone treatment in prisons in Moldova, compared to 
22 prisoners in August 2007.iii A cumulative total of 120 prisoners have received 
methadone while incarcerated since the program began in 2005. 
Vovc said that the number of prisoners beneﬁting from the program has 
been increasing slowly since eligibility criteria have been relaxed and the program 
has been expanded to a greater number of facilities, including the women’s prison 
in Rusca.iv
 History of the Methadone Program in Prison
The ﬁrst step toward methadone in prisons began in 2003, when staff from Soros 
Foundation–Moldova approached the Department of Penitentiary Institutions about 
initiating methadone in prisons at the same time, or shortly after, its introduction in 
the community in Moldova. Among other things, foundation staff pointed to the suc-
cess of IPP’s harm reduction project and suggested that methadone would comple-
ment that project’s efforts by providing even more options for prisoners seeking to 
limit drug use-related risks to their health. 
The department agreed in principle, but said that decision makers needed 
more information about how such a program might operate. In May 2004, Vladimir 
Tsaranu, then head of medical services in the department, together with Vladimir 
Troﬁm, the department’s director general, and Dumitru Laticevschi,v went on a 
study tour to Canada, funded by OSI’s International Harm Reduction Development 
Program and organized by the Canadian HIV/AIDS Legal Network. They visited 
OST programs in several prisons and in the community, spent time with the 
experts who had designed and implemented the prison system’s OST program, and 
spoke to prisoners on OST. They also met with prison staff who said that, while 
they had initially been skeptical about the program, they now fully supported it, 
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having seen the positive impact it has not only on the health of prisoners, but 
also on the prison environment. Tsaranu also had an opportunity to meet expert 
consultants from the Netherlands who toured several Moldovan prisons with him 
and other colleagues. 
Shortly after the visit to Canada, the program received the green light from 
all relevant government ofﬁcials. Before leaving Canada, Troﬁm had said to his 
Canadian colleagues that he had been convinced of the beneﬁts of the program, and 
would start it as soon as possible in his prisons. Tsaranu’s department explained the 
program to prison administrators and staff, notably those from local medical units 
(which would be in charge of administering methadone). Leaﬂets about the program, 
with particular focus on the health beneﬁts of methadone treatment, were then dis-
tributed throughout several prisons. Potentially eligible prisoners were urged to apply 
to participate in the program.
The criteria for inclusion, inside and outside prisons, initially were very strict, 
severely limiting access to the program. They included the following: 1) drug depen-
dent for at least two years, with injecting being the main method of drug delivery; 
2) HIV-positive; 3) on ART; and 4) clear evidence of the individual’s strong desire 
to participate and, especially, to stop using drugs. A prisoner could meet the fourth 
criterion by, for example, writing a letter to prison administrators stating how and 
why drug use had caused destruction and havoc in his life. 
A total of 10 prisoners applied during the initial application period. In July 
2005, four of them were selected by a special commission comprising penitentiary 
system administrators. At the beginning, the four participants were isolated at a 
special prison hospital so ofﬁcials could monitor the program closely. Within a year, 
however, medical staff at individual prisons were given responsibility for administer-
ing methadone on-site. 
Admission criteria have since been relaxed, and an evaluation undertaken 
by an international expert documented other positive developments that have led 
to increased access to, and quality of, methadone treatment in prisons.vi The main 
document which regulates methadone in Moldova, “The Order of the Ministry of 
Health on the OST” (2003), was modiﬁed in 2008. In order to be included in the 
methadone treatment program, now only the informed consent of a patient with 
opioid dependence is required. Patients must be 18 years or older. HIV, TB, and 
hepatitis C are additional indications for methadone treatment.vii Among the most 
important other positive developments is the possibility to continue methadone with 
maintenance doses in prisons beyond six months. Previously, patients had to gradu-
ally reduce their methadone dose during a period of six months.viii
Despite the positive changes, the overall number of prisoners in the methadone 
treatment program remains very low. Victor Vovc noted that, while it was initially 
hard to convince prison directors of the need to start OST at their institutions, 
“this has changed and staff are now more tolerant and understanding.”ix He added: 
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“Today, many chiefs of prisons would like to open an OST program in their prisons. 
We have all seen the good results. Prisoners now also know the program and 
many are eager and willing to start the treatment.” One of the people who witnessed 
the positive results of the program is Constantin Birca, who has been responsible 
for the program at prison #15 in Cricova since 2007. According to him, “the program 
should have been introduced a long time ago. Many problems have decreased for us. 
Prisoners on methadone are doing much better and they are much more disciplined—
not always seeking to ﬁnd drugs as before, but really trying to get well.”x
Prisoners on methadone who spoke with one of the researchers semi-private-
lyxi discussed at great lengths the positive impact the treatment has on their health 
and general well-being. One prisoner, who is living with HIV, said: “Before I started 
[the treatment], I was in the medical unit most of the time. Now I am well.” Another 
said: “I used to be nervous, unstable, always thinking about how to get drugs. Now 
I am more quiet and conﬁdent, and able to make the right decisions for myself and 
think about the future.” A third prisoner added: “Methadone treatment is a big relief. 
I can concentrate on my needs now, not only on drug use as before. My mother, my 
brothers and sisters, are all very happy, and I know I will be able to help them when 
I will be released, rather than being a burden all the time.”
Challenges and Obstacles
The current and former heads of medical services in the national Department of 
Penitentiary Institutions acknowledged that there have been numerous challenges 
since the program began. Among them are the following: 
Limited Availability of Methadone Treatment in the Community Outside Prisons
Despite a recent marked increase in patients on methadone in the community (from 
17 in July 2007 to around 140 in August 2008) and despite many other substantial 
improvements to methadone provision in Moldova,xii the overall coverage in the 
country remains very low, with less than one percent of the estimated number of 
people who inject opioids on methadone. As of August 2008, methadone programs 
were available only in the capital, Chisinau, and in one other major center, Balti.
While the Ministry of Health and Department of Penitentiary Institutions 
offer separate methadone programs, limited access to methadone in the community 
affects access to, and continuation of, methadone in prisons. The heads of medical 
services and their staff have worked closely with the Ministry of Health to ensure that 
prisoners on methadone are automatically eligible for programs outside of prison 
once they are released. “We work hard to ensure continuity of treatment. We give 
them [prisoners on methadone about to be released] a certiﬁcate specifying their 
dose and they can be on a program outside within one hour of their release,”xiii said 
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Birca. “If problems arise we resolve them working with our colleagues in community 
programs. But prisoners who are not from Chisinau or Balti have a problem.” 
Continued Limited Methadone Availability in Penitentiary Institutions
Everyone agreed that there was a need to vastly increase the number of treatment 
places and to increase the number of institutions with a methadone treatment pro-
gram: prisoners and staff in prisons with an existing methadone treatment pro-
gram said that many other prisoners would like to be on the program; prisoners or 
staff in prisons without a methadone program said it was time that the program be 
expanded to include their institution; and the international expert who evaluated the 
methadone program in Moldova also called for greater access.xiv
Another priority should be to make the program available in at least some of 
the pretrial detention facilities and to ensure that detainees who are on methadone 
treatment at the time of their arrest and pretrial detention can continue the treat-
ment without interruption. Unassisted withdrawal from methadone constitutes cruel 
and unusual punishment, and patients who are not able to continue treatment upon 
detention often return to injecting drug use.xv During the visit to the pretrial detention 
facility in Balti, one of the researchers had a semi-private interview with a detainee 
living with HIV who had been a client of a methadone program on the outside. He 
had been transferred to the facility the day before and was starting to experience 
withdrawal from methadone; the detainee was in a panic and asked for help. Clearly, 
he should have been able to continue his treatment without interruption.
Opposition from Other Government Ofﬁcials
According to Tsaranu, one major early problem stemmed directly from the easy 
and regular availability of media originating from Russia, where methadone treat-
ment is banned. It is difﬁcult for Moldovans—nearly all of whom speak Russian—to 
avoid anti-methadone stories that regularly appear in Russian media outlets. Tsaranu 
said that such stories greatly inﬂuenced the Moldovan Ministry of Justice, whose 
strong opposition to methadone was only overcome by successful advocacy by the 
Ministry of Health. Justice ofﬁcials eventually were ordered to accept the legal use 
of methadone to treat drug dependence. The main battle, Tsaranu said, was fought 
by the Ministry of Health as it sought permission to launch OST through the main 
healthcare system. The battle had largely been won by the time the Department of 
Penitentiary Institutions became involved.
Diversion of Methadone
Both the current and former heads of medical services in the Department of 
Penitentiary Institutions said there had initially been concerns about diversion of 
methadone. Tsaranu spoke of prisoners in the methadone program attempting to 
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bribe medical personnel so they could take the methadone to prisoners not in the 
program. He also mentioned instances when participants had been forced by other 
prisoners to vomit upon returning from drinking their daily methadone dose. The 
vomit would then be dried by another prisoner, who would ingest the remains. 
Tsaranu and Vovc however reported that these concerns had been success-
fully addressed, following the example of other prison systems with methadone pro-
grams.xvi Methadone is now administered under strict supervision, in the presence 
of three people observing the intake: a doctor, a medical assistant, and a security 
guard. Clients also have to stay for at least 10 minutes after drinking their dose, and 
are asked to speak to ensure they swallow their dose. Vovc added that another reason 
why diversion is no longer an issue is that, as soon as there are several people on 
the methadone program in a particular prison, the group auto-regulates itself and 
its members protect themselves. “If someone is pressured by another prisoner, the 
group protects him. If the group cannot manage the problem, it informs the medi-
cal personnel and we help the person. This works well and diversion is no longer 
an issue.”xvii 
Supply Limitations
Methadone is kept in the prison’s pharmacies where there is an alarm and a safe 
to securely store the methadone. The program’s guidelines stipulate that local 
prison authorities can have on hand a maximum of 10 days’ supply of methadone 
at any given time. That rule was imposed, according to Tsaranu, because metha-
done remains technically illegal in Moldova and is ofﬁcially considered a dangerous 
narcotic. The rule is a hassle, he added, because it can be hard to move supplies 
around the country so frequently on a regular basis. He said he hoped it would be 
possible for the policy to be relaxed once the program becomes more entrenched 
and key people are more accustomed to it, especially opponents in law enforcement 
agencies.
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6. Advice from Program
  Implementers
Over the last ten years, Moldova has shown that comprehensive harm reduction ser-
vices and methadone programs can successfully be implemented in prisons, even 
in a resource-poor country. While challenges remain, the work undertaken by the 
Department of Penitentiary Institutions, the NGO, and others who made implemen-
tation of the programs possible, represents international best practice that can and 
should help and inspire other countries and their prison systems. 
Staff at both the NGO and the Moldovan penitentiary system consistently 
expressed the view that the beneﬁts of provision of comprehensive harm reduction 
services and methadone, for individual prisoners’ health, for the prison system, and for 
public health, far outweigh concerns that, for example, needle exchange and condom 
distribution could promote illegal or immoral behavior. They pointed out that there 
is no evidence from Moldovan prisons that illegal drug use increased in the wake of 
the implementation of the needle and syringe program, and that it is impossible to 
completely stop illegal drugs from entering prisons or prisoners from using them. 
According to them, the “immoral” response is therefore one that denies prisoners the 
means to protect themselves from harm.
Several people interviewed for this report offered advice for individuals, organi-
zations, and prison systems committed to following international recommendations 
by implementing comprehensive HIV programs in prisons, including needle and 
syringe programs and methadone maintenance treatment. 
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Below are some of those observations.
Vladimir Troﬁm, Department of Penitentiary Institutions87 
• Advice for penitentiary ofﬁcials: “The most important thing is to learn 
to take responsibility for the things you do. If your fate is to be a deci-
sion-maker, you should do it in the most realistic way possible. You must 
help people if you can. Helping them doesn’t require a big technical back-
ground...just a commitment.”
• Advice for NGOs: “Convince someone like myself, a government ofﬁcial 
in a decision-making post, of the merits and importance of your project. 
Often your ability to move forward can depend on the will of one person. 
Persistence is key. NGOs must not be afraid, especially if they have sta-
tistics that prove their case. For example, I was convinced by the results 
of the ﬁrst anonymous survey done by the NGO in 1999. The extent and 
type of drug use in prisons were shocking to me, and I knew we had to do 
something very different in response.” 
Oleg Borduja, Cricova Prison Colony 1588 
• “I’d advise prison medical staff, especially directors, to research and ﬁnd 
numerous examples of the positive impact of harm reduction programs. 
The positive effect should be evident both in terms of the health of pris-
oners and safety of staff. Armed with this data, you can then explain why 
harm reduction leads to these outcomes. And don’t forget that a person 
who is well-informed is well-protected.” 
Larisa Pintilei, Innovative Projects in Prisons89 
• “My advice is for other NGOs, and it has several parts: 
  1. Realize and accept that harm reduction must be done. This must be 
the ﬁrst step.
  2. When you provide harm reduction services, you must ensure that as 
many people as possible have consistent and easy access to them. 
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  3. If possible, approach and convince top-level ofﬁcials at ﬁrst. Our 
ability to do this is perhaps the single most important factor behind 
our success in covering the majority of facilities and reaching several 
thousand prisoners.
  4. Provide training on an ongoing basis for administrative staff at all 
levels, from top to bottom. If possible, we regularly train prison staff 
at all our facilities. And we brief the senior administration of the 
penitentiary department on our activities, achievements and chal-
lenges on a regular basis. We even invited senior administration 
staff to international conferences on harm reduction so they could 
see for themselves what’s being done elsewhere and what’s pos-
sible.
  5. Regularly monitor and evaluate your activities so that you can dem-
onstrate that you are achieving good results.
  6. Don’t be afraid to start new initiatives—you will be successful! Good 
luck!”
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